window.dataLayer = window.dataLayer || []; function gtag(){dataLayer.push(arguments);} gtag('js', new Date()); gtag('config', 'G-4PR1PSYQLJ'); Skip to content

Welcome to Discover Pharma! Today is : May 4, 2026

  • News
  • Featured News Archives
    • 12 Days of Christmas
    • Women in Pharma
  • About Us
Contact Us

CDMOs & Manufacturing

  • CDMOs & Manufacturing,Women in Pharma

    Women in Pharma: Jenny Gattari on mentorship, manufacturing and making a difference

    Purpose, precision and progress: Jenny's advice on building a career that delivers. With more than 30 years of cross-functional experience spanning manufacturing, R&D, supply chain and commercial strategy, Jenny Gattari brings a rare depth of insight to her role as Global Business Development Lead at Pfizer CentreOne.

    February 15, 2026
  • Biologics & Biosimilars,CDMOs & Manufacturing,Drug Delivery & Formulation,Market Access & Commercialization,Partnerships & Funding

    XL-protein grants global licence to Grifols for long-acting biologic using PASylation technology

    PASylated candidate to advance into preclinical development under new agreement [...]

    June 11, 2025
  • Biologics & Biosimilars,CDMOs & Manufacturing,Drug Delivery & Formulation,Drug Development,Partnerships & Funding

    Axio and Likarda team up to streamline biologic drug delivery and manufacturing

    Axio BioPharma and Likarda have announced a strategic collaboration designed [...]

    June 10, 2025
  • Biologics & Biosimilars,CDMOs & Manufacturing,Cell & Gene Therapy,Partnerships & Funding,Regulatory Affairs

    Unlocking collective intelligence: Why cell and gene therapy needs a data-sharing revolution

    Alexander Seyf, CEO of Autolomous, explains how collaboration—not competition—is the [...]

    June 10, 2025
  • Biologics & Biosimilars,CDMOs & Manufacturing,Cell & Gene Therapy,Regulatory Affairs

    Is Europe rising? How global pharma uncertainty is fuelling a new era for European innovation

    As global pharma grapples with shifting regulations, rising geopolitical tensions, [...]

    June 8, 2025
  • Biologics & Biosimilars,CDMOs & Manufacturing,Drug Delivery & Formulation,Supply Chain & Logistics

    Tjoapack expands biologics packaging and cold chain capacity in USA and Europe

    Tjoapack, a leading contract packaging organization serving the pharmaceutical industry, [...]

    June 9, 2025
  • CDMOs & Manufacturing,Regulatory Affairs,Supply Chain & Logistics

    Axplora’s Chasse-sur-Rhône site completes ninth consecutive regulatory inspection without critical remarks

    Axplora has confirmed the successful outcome of its latest inspection [...]

    June 8, 2025
  • Biologics & Biosimilars,CDMOs & Manufacturing,Cell & Gene Therapy,Drug Development

    Fujifilm life sciences companies rebrand to strengthen end-to-end drug development solutions

    Fujifilm Corporation’s Life Sciences Group has rebranded its key companies [...]

    June 2, 2025
  • CDMOs & Manufacturing,Cell & Gene Therapy,Drug Delivery & Formulation,Drug Development

    Inside CTMC: Innovating cell therapy development from patient to clinic

    Cell therapy has emerged as one of the most promising [...]

    May 30, 2025
  • Artificial Intelligence,Biologics & Biosimilars,CDMOs & Manufacturing,Partnerships & Funding,Regulatory Affairs

    CytoImmune backs US reshoring push with major biomanufacturing expansion in Puerto Rico

    In response to President Donald Trump’s executive order promoting domestic [...]

    May 29, 2025
Previous131415Next

Bringing you the latest industry news and insights every day

Registered Address: Discover Pharma Ltd, 1 Dartmouth Close, Brighton, BN2 4HZ, UK
Company Number: 16239596

  • About Us
  • Contact Us
  • Legal
    • Cookie Policy
    • Privacy Policy
    • Terms & Conditions
  • Author Guidelines
    • Pharmaceutical Author Guidelines
    • Press Release Advice
  • Advertise with Us
  • Media Kit Request

© 2026 Discover Pharma. All rights reserved • Developed by Hairy Goat Design

Page load link

Press “ESC” key to close

main menu
  • Home
  • News
  • About Us
  • Contact
recent posts
  • Cereno Scientific reports long-term safety data from CS1 pulmonary arterial hypertension program
    Categories: Cardiovascular diseases, Clinical Trials, Rare Diseases, Regulatory Affairs, Research & Development
  • City St George’s and Paradigm Biopharmaceuticals study osteoarthritis pain drug mechanism
    Categories: Clinical Trials, Neurosciences, Partnerships & Funding, Research & Development
  • BIOGRUND and Seprify launch plant-based tablet coating to replace titanium dioxide
    Categories: Ingredients, Manufacturing, Packaging, Pharmaceuticals and therapeutics
get connected
This website uses cookies and third party services. See our Cookie Policy and Privacy Policy pages for details. OK
Go to Top